XBiotech
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-33.94-8.93-6.21-4.14-8.601.08-42.98-19.20-3.24-4.93-2.22-8.60
Price/Sales ratio
N/AN/AN/AN/AN/AN/A10.9618.1726.64N/A18.39N/A
Price/Book Value ratio
12.493.245.552.284.390.961.381.240.440.550.460.96
Price/Cash Flow ratio
-63.02-10.05-7.12-4.08-10.99-39.78-7.404.81-7.20-6.47-4.22-10.99
Price/Free Cash Flow ratio
-56.30-7.66-5.47-3.91-10.91-39.34-7.005.07-6.93-6.35-4.09-10.91
Price/Earnings Growth ratio
-0.28-0.11-0.180.090.22-0.000.42-0.31-0.030.190.030.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A22.43%N/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A21.47%68.35%83.76%N/A82.26%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-41.53%-136.35%-860.09%N/A-901.14%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-29.15%-138.40%-837.60%N/A-898.90%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-25.50%-94.67%-820.44%N/A-826.80%N/A
Effective Tax Rate
0.24%0.01%0.00%2.74%0.68%6.93%12.52%31.59%2.04%-1.00%5.48%0.68%
Return on Assets
-34.93%-34.27%-78.68%-52.64%-47.66%81.85%-3.17%-6.32%-13.36%-10.83%-20.29%-47.66%
Return On Equity
-36.80%-36.37%-89.32%-55.10%-51.06%88.48%-3.21%-6.46%-13.68%-11.22%-19.84%-51.06%
Return on Capital Employed
-36.89%-36.39%-89.29%-56.59%-50.70%-4.12%-5.22%-9.23%-14.24%-17.01%-22.48%-50.70%
Liquidity Ratios
Current Ratio
N/A14.784.6311.935.7711.9081.79N/AN/AN/A54.065.77
Quick Ratio
18.4514.784.6311.935.7711.9083.4474.0854.0633.0638.985.77
Cash ratio
18.2114.474.3111.375.3711.8759.5768.6338.6832.7938.685.37
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A34.12177.65160.56N/A73.48N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A-69.45-561.48N/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A-35.33-383.82160.56N/A18.11N/A
Days of Payables Outstanding
N/A2.51K2.31K425.50247.98332.2226.31129.751.35K526.57820.65247.98
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-61.65-513.58-1.18KN/A-747.17N/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-159.14N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.051.061.131.041.071.081.011.021.021.031.021.08
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-1.483.77-3.69N/A-4.35N/A
Free Cash Flow / Operating Cash Flow Ratio
1.111.311.301.041.001.011.050.941.031.011.031.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-430.70%N/AN/AN/AN/A